The post Novo Nordisk Stock Surges 6% As Wegovy Pill Sales Crush Estimates appeared first on Coinpedia Fintech News
Novo Nordisk shares climbed more than 6% in early trading on Wednesday after its Wegovy pill outsold expectations and the company raised its full-year guidance. The Danish drugmaker now expects adjusted revenue and operating profit to range from a 2% decline to 2% growth at constant exchange rates, up from a previous forecast of minus …
